Management of Lobular Neoplasia Diagnosed by Core Biopsy

被引:3
|
作者
Jani, Chinmay [1 ,2 ]
Lotz, Margaret [2 ,3 ,4 ]
Keates, Sarah [2 ,3 ,4 ]
Gupta, Yasha [2 ,5 ]
Walker, Alexander [1 ,2 ]
Al Omari, Omar [1 ,2 ]
Parvez, Arshi [1 ,2 ]
Patel, Dipesh [2 ,5 ]
Gnata, Maria [4 ]
Perry, John [6 ]
Khorashadi, Leila [2 ,5 ]
Weissmann, Lisa [1 ,2 ,3 ]
Pories, Susan E. [2 ,4 ]
机构
[1] Mt Auburn Hosp, Dept Internal Med, 300 Mt Auburn St, Cambridge, MA USA
[2] Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA
[3] Mt Auburn Hosp, Div Hematol Oncol, 300 Mt Auburn St, Cambridge, MA USA
[4] Mt Auburn Hosp, Hoffman Breast Ctr, Dept Surg, 300 Mt Auburn St, Cambridge, MA 02138 USA
[5] Mt Auburn Hosp, Dept Radiol, 300 Mt Auburn St, Cambridge, MA USA
[6] Mt Auburn Hosp, Dept Pathol, 300 Mt Auburn St, Cambridge, MA USA
来源
BREAST JOURNAL | 2023年 / 2023卷
关键词
NEEDLE-BIOPSY; IN-SITU; BREAST; CARCINOMA; RISK;
D O I
10.1155/2023/8185446
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). LCIS can be further subdivided into three subtypes: classic LCIS, pleomorphic LCIS, and LCIS with necrosis (florid type). Because classic LCIS is now considered as a benign etiology, current guidelines recommend close follow-up with imaging versus surgical excision. The goal of our study was to determine if the diagnosis of classic LN on core needle biopsy (CNB) merits surgical excision. This is a retrospective, observational study conducted at Mount Auburn Hospital, Cambridge, MA, from May 17, 2017, through June 30, 2020. We reviewed the data of breast biopsies conducted at our hospital over this period and included patients who were diagnosed with classic LN (LCIS and/or ALH) and excluded patients having any other atypical lesions on CNB. All known cancer patients were excluded. Of the 2707 CNBs performed during the study period, we identified 68 women who were diagnosed with ALH or LCIS on CNB. CNB was performed for an abnormal mammogram in the majority of patients (60; 88%) while 7(10.3%) had an abnormal breast magnetic resonance imaging study (MRI), and 1 had an abnormal ultrasound (US). A total of 58 patients (85%) underwent excisional biopsy, of which 3 (5.2%) showed malignancy, including 2 cases of DCIS and 1 invasive carcinoma. In addition, there was 1 case (1.7%) with pleomorphic LCIS and 11 cases with ADH (15.5%). The management of LN found on core biopsy is evolving, with some advocating surgical excision and others recommending observation. Our data show a change in diagnosis with excisional biopsy in 13 (22.4%) of patients with 2 cases of DCIS, 1 invasive carcinoma, 1 pleomorphic LCIS, and 9 cases of ADH, diagnosed on excisional biopsy. While ALH and classic LCIS are considered benign, the choice of ongoing surveillance versus excisional biopsy should be made with shared decision making with the patient, with consideration of personal and family history, as well as patient preferences.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Lobular Neoplasia in Core Biopsy of Breast: Clinical Implications
    Speiser, J. J.
    Drinka, E.
    Godellas, C.
    Perez, C.
    Salhadar, A.
    Ersahin, C.
    Sinacore, J.
    Rajan, P.
    LABORATORY INVESTIGATION, 2011, 91 : 64A - 65A
  • [22] Routine Excision of Core Biopsy Diagnosed Flat Epithelial Atypia Frequently Reveals ADH and Lobular Neoplasia: Potential Implications for Management
    Ho, C. S.
    Yap, W. M.
    LABORATORY INVESTIGATION, 2010, 90 : 51A - 51A
  • [23] Routine Excision of Core Biopsy Diagnosed Flat Epithelial Atypia Frequently Reveals ADH and Lobular Neoplasia: Potential Implications for Management
    Ho, C. S.
    Yap, W. M.
    MODERN PATHOLOGY, 2010, 23 : 51A - 51A
  • [24] Management and Upgrade of Pleomorphic Lobular Carcinoma In Situ Diagnosed on Core Needle Biopsy
    Wahidi, Marya
    Lanchoney, Olivia
    Larson, Lauren
    Abbott, Sara
    Yousif, Mustafa
    Ali-Fehmi, Rouba
    Chapel, Ellen
    LABORATORY INVESTIGATION, 2025, 105 (03)
  • [25] Long-Term Follow-up of Lobular Neoplasia (Atypical Lobular Hyperplasia/Lobular Carcinoma In Situ) Diagnosed on Core Needle Biopsy
    Miraj G. Shah-Khan
    Xochiquetzal J. Geiger
    Carol Reynolds
    James W. Jakub
    Elizabeth R. DePeri
    Katrina N. Glazebrook
    Annals of Surgical Oncology, 2012, 19 : 3131 - 3138
  • [26] Long-Term Follow-up of Lobular Neoplasia (Atypical Lobular Hyperplasia/Lobular Carcinoma In Situ) Diagnosed on Core Needle Biopsy
    Shah-Khan, Miraj G.
    Geiger, Xochiquetzal J.
    Reynolds, Carol
    Jakub, James W.
    DePeri, Elizabeth R.
    Glazebrook, Katrina N.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (10) : 3131 - 3138
  • [27] Lobular Neoplasia and Atypical Ductal Hyperplasia on Core Biopsy: Current Surgical Management Recommendations
    Jennifer M. Racz
    Jodi M. Carter
    Amy C. Degnim
    Annals of Surgical Oncology, 2017, 24 : 2848 - 2854
  • [28] Lobular Neoplasia and Atypical Ductal Hyperplasia on Core Biopsy: Current Surgical Management Recommendations
    Racz, Jennifer M.
    Carter, Jodi M.
    Degnim, Amy C.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (10) : 2848 - 2854
  • [29] The management of atypical lobular hyperplasia and lobular carcinoma in-situ diagnosed by core biopsy: is surgical excision necessary?
    Cangiarella, J.
    Axelrod, D.
    Guth, A.
    Singh, B.
    Skinner, K.
    Roses, D.
    Simsir, A.
    Mercado, C.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S176 - S176
  • [30] Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?
    Cangiarella, Joan
    Guth, Amber
    Axelrod, Deborah
    Darvishian, Farbod
    Singh, Baljit
    Simsir, Aylin
    Roses, Daniel
    Mercado, Cecilia
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2008, 132 (06) : 979 - 983